“…The influenza A virus is the causative agent of yearly epidemics and occasional pandemics 4 and numerous microfluidic technologies have been developed to detect the presence of influenza A viral RNAs in clinical samples. Devices employed in these technologies include microfluidic chips, [5][6][7][8][9][10][11][12][13][14][15] integrated Microsystems, [16][17][18][19][20] and lateral flow strips. 8,[21][22] The detection methodologies include RT-qPCR, 15, 17, 20, 23-26 electrophoretic immunoassays, 27 PCR-capillary electrophoresis, 11-14, 18, 29 immunochromatography, 8,19,[21][22] microarray, 5,9,16,[30][31][32] and electrochemical approaches.…”